Topical skin care composition

Details Topical skin care composition Topical skin care composition

2011-03-29

2011-03-29

Richter, Johann R (Department: 1627)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

C514S721000, C514S731000

Reexamination Certificate

active

07915243

ABSTRACT:
A cream base for the topical application of skin care therapeutics and a process for making the cream base. In one embodiment, the therapeutic is tretinoin, hydroquinone and fluocinolone acetonide for the treatment of hyperpigmented skin conditions, such as melasma.

REFERENCES:
patent: 1429430 (1922-10-01), Holmes et al.
patent: 2164723 (1939-07-01), Schrauth et al.
patent: 3226295 (1965-12-01), Goetz et al.
patent: 3776857 (1973-12-01), Lindner
patent: 3856934 (1974-12-01), Kligman
patent: 3906108 (1975-09-01), Felty
patent: 3966924 (1976-06-01), Frediksson
patent: 4146499 (1979-03-01), Rosano
patent: 4254104 (1981-03-01), Suzuki
patent: 4427670 (1984-01-01), Ofuchi et al.
patent: 4603146 (1986-07-01), Kligman
patent: 4654373 (1987-03-01), Bertelli
patent: 4737360 (1988-04-01), Allen
patent: 4857321 (1989-08-01), Thomas
patent: 4992478 (1991-02-01), Geria
patent: 5145604 (1992-09-01), Neumiller
patent: 5514698 (1996-05-01), Ahmad et al.
patent: 5538737 (1996-07-01), Leonard et al.
patent: 5573781 (1996-11-01), Brown
patent: 5626873 (1997-05-01), Weiner
patent: 5645854 (1997-07-01), Masiz
patent: 5651991 (1997-07-01), Sugiyama
patent: 5656672 (1997-08-01), Collin et al.
patent: 5660837 (1997-08-01), Lundquist
patent: 5744148 (1998-04-01), Habif et al.
patent: 5851543 (1998-12-01), Korb
patent: 5935589 (1999-08-01), Mulcherjee et al.
patent: 5951993 (1999-09-01), Scholz et al.
patent: 5962512 (1999-10-01), Goupil
patent: 5972359 (1999-10-01), Sine et al.
patent: 5976555 (1999-11-01), Liu et al.
patent: 5997890 (1999-12-01), Sine et al.
patent: 6001377 (1999-12-01), SaNogueira et al.
patent: 6030623 (2000-02-01), Meade
patent: 6080393 (2000-06-01), Liu et al.
patent: 6090395 (2000-07-01), Asmus et al.
patent: 6139824 (2000-10-01), Ribery et al.
patent: 6153657 (2000-11-01), Kisuno et al.
patent: 6174533 (2001-01-01), SaNogueira et al.
patent: 6267985 (2001-07-01), Chen
patent: 6365656 (2002-04-01), Green
patent: 6383499 (2002-05-01), Lipi
patent: 6413536 (2002-07-01), Gibson
patent: 6423323 (2002-07-01), Neubourg
patent: 2005/0101580 (2005-05-01), Puglia et al.
patent: 2006/0099173 (2006-05-01), Puglia et al.
patent: 2008/0007846 (2008-01-01), Wu et al.
patent: 2 833 841 (2003-06-01), None
patent: 01-203036 (1999-08-01), None
patent: 1999-0087346 (1999-12-01), None
patent: 2000-0073077 (2000-12-01), None
patent: 2001-0089781 (2001-10-01), None
patent: WO-2004/037201 (2004-05-01), None
FDA, Tri-LumaTM approval letter (Jan. 18, 2002).
Galderma Laboratories, Tri-LumaTM prescribing information (Jan. 2002).
Office Action for U.S. Appl. No. 11/114,426 (Nov. 24, 2009).
PCT International Search Report (Aug. 27, 2004).
Lack et al., New Eng J Med, 348(11):977-85 (2003).
Lever, B Med J, 313:299-300 (1996).
Taylor et al., J Allergy Clin Immunol, 68(5):372-75 (1981).
Journal of the American Academy of Dermatology, vol. 52, No. 3, Mar. 2005, P168.
Declaration of Sandrine Segura (Sep. 11, 2007).
Declaration of Sandrine Segura, Exhibit A (curriculum vitae of Sandrine Segura).
Declaration of Sandrine Segura, Exhibit B (Tri-Luma® Cream manufacturing procedure).
Declaration of Sandrine Segura, Exhibit C (Uniqema specification for Arlacel (TM)165).
Declaration of Sandrine Segura, Exhibit D (results of side-by-side study).
Second Declaration of Sandrine Segura (Oct. 17, 2008).
Second Declaration of Sandrine Segura, Exhibit 1 (rheological curves).
Second Declaration of Sandrine Segura, Exhibit 2 (Tri-Luma® Cream Label).
Second Declaration of Sandrine Segura, Exhibit 3 (Advances in Pharmaceutical Sciences, vol. 1: 22-24 (H.S. Bean, A.H. Beckett And J.E. Carless 1964).
Second Declaration of Sandrine Segura, Exhibit 4 (On-Line Medical Dictionaryathttp://cancerweb.ncl.ac.uk/cgi-bin/omd?query=viscosity).
Declaration [of Nancy Puglia] Under 37 C.F.R. § 1.131 (Feb. 25, 2008).
Declaration [of Nancy Puglia] Under 37 C.F.R. § 1.131, Exhibit A (excerpt of batch record for Tri-Luma® Cream) (Feb. 25, 2008).
Declaration [of Nancy Puglia] Under 37 C.F.R. § 1.131 (May 1, 2009).
Declaration [of Nancy Puglia] Under 37 C.F.R. § 1.131, Exhibit 1 (excerpt of batch record for Tri-Luma® Cream) (May 1, 2009).
L'Oreal Annual Report (2002).
E. Sagarin, Cosmetics Science and Technology, p. 1004 (Interscience Publishers, Inc. 1957).
Handbook of Pharmaceutical Excipients (3rd edition, 2000) pp. 117-120 and 537-538.

Affiliated with

Also associated with

Rating

Topical skin care composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Topical skin care composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical skin care composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2781274